Categories AlphaGraphs, Consumer, Earnings

Darden Restaurants reports upbeat Q3 earnings, declares dividend

Olive Garden and LongHorn Steakhouse parent Darden Restaurants, Inc. (DRI) announced its third-quarter 2019 earnings results before the opening bell on Thursday, Mar. 21.

Total sales spiked 5.5% to $2.25 billion for the three-month period, due to 39 net new restaurants and a blended same-restaurant sales rise of 2.8%.

Net earnings from continuing operations in the quarter rose 3.4% to $1.80 per diluted share, or $225.1 million. Total net earnings were $223.6 million, or $1.79 per diluted share.

An infographic on Darden Restaurants' third quarter 2019 earnings results
Darden Restaurants Q3 2019 Earnings Infographic

According to Zacks Research, analysts expected quarterly earnings of $1.75 per share on revenues of about $2.24 billion.

NEW OUTLOOK FOR 2019, NEW DIVIDEND

In addition to the earnings results, Darden Restaurants board declared a regular quarterly dividend of $0.75 per share on the outstanding common stock.

READ: Conagra Brands Q3 earnings dip 33%

The cash dividend is payable on May 1, 2019 to shareholders on record at the close of business on April 10, 2019.

Total sales growth for fiscal 2019 is now expected to be about 5.5%, with same-restaurant sales growth at an estimated 2.5-2.7%. Darden is looking at an effective tax rate of approx. 10%, without earnings from continuing operations expected to be between $5.76 and $5.80 per diluted share.

 

 

Earnings Calendar: Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top